Bioequivalence Study without approved/marketed or no RLD [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-03-13 09:37 (1733 d 03:11 ago) – Posting: # 21261
Views: 4,339

Hello All,

Greetings!!

We got an inquiry to conduct BE for XYZ molecule but at the time of feasibility we came to know that RLD for XYZ molecule is not approved/marketed in our country. Means there is no RLD.

Still sponsor wants to market their product. In this case, what we can do? Can we do directly PK study or Phase III study of sponsor's product in patients?

Thanks.

Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,336 posts in 4,902 threads, 1,667 registered users;
68 visitors (0 registered, 68 guests [including 12 identified bots]).
Forum time: 12:48 CET (Europe/Vienna)

Every man is fully satisfied that there is such a thing as truth,
or he would not ask any question.    Charles Sanders Peirce

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5